A Study to Compare the Efficacy and Safety of a Combination of Ketoconazole and Clindamycin Compared to Tetracycline/Amphotericin B Combination Cream for the Treatment of Bacterial Vaginosis and Vaginal Candidiasis (P08077)

NCT01293643 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

99

Enrollment

INDUSTRY

Sponsor class

Conditions

Vaginosis, Bacterial
Candidiasis, Vulvovaginal

Interventions

DRUG: 100 mg clindamycin /800 mg ketoconazole vaginal ovule
DRUG: 100 mg tetracycline hydrochloride /50 mg amphotericin B cream

Sponsor

Merck Sharp & Dohme LLC